Much of the attention in cataract surgery during
the past 2 decades has focused on improving
the safety and efficacy of the procedure. More
recently, there has been greater awareness of
the need to achieve more consistent refractive outcomes.
…
Author: Advanced Ocular Care
Do 5-Year TVT Data Point to a Superior Surgery?
The release of 5-year follow-up data from the
Tube Versus Trabeculectomy (TVT) study may
help finally resolve the question of which technique
would perform better among glaucoma
patients who previously failed filtering surgery.
Earlier report…
Intra-arterial Chemotherapy Safe, Effective for Retinoblastoma
Intra-arterial chemotherapy was safe and effective in the treatment of advanced intraocular retinoblastoma, according to a study in the Archives of Ophthalmology.sup1/sup
In a single-armed, prospective study, Y. Pierre Gobin, MD, of Weill Cornell Medi…
Correction
The units of measurement were listed incorrectly in Table 1 of the “Peer Review” article in the March 2011 issue of emAdvanced Ocular Care/em. The measurement mg/mL should have appeared as μg/mL throughout the table. We regret the error and any co…
Kentucky House Approves More Optometric Procedures
A bill recently approved by the Kentucky legislature and signed into law by Gov. Steve Beshear will allow optometrists to perform certain medical procedures currently reserved for ophthalmologists. The legislation allows optometrists to administer phar…
LensAR Receives FDA Clearance for Lens Fragmentation in Cataract Surgery
LensAR, Inc. (Orlando, FL), announced that it has received 510(k) clearance from the FDA for the use of the LensAR Laser System for lens fragmentation in addition to anterior capsulotomy during cataract surgery.
“Receiving the additional FDA indicat…
Ista Files Citizen Petition With FDA
Ista Pharmaceuticals, Inc. (Irvine, CA), announced that it filed a citizen petition with the FDA on March 1, 2011. The petition requests that the federal agency refrain from granting tentative or final approval of any abbreviated new drug application f…
First Retinal Prosthetic Implant Approved in Europe
After 20 years of research and development, the first retinal prothesis has received European approval for clinical and commercial use.
PThe Argus II Retinal Prosthesis System (Second Sight Medical Products, Inc., Sylmar, CA) received CE Mark approval …
Alimera Reports 36-Month Results From Phase 3 FAME Study
The completed 36-month results of the phase 3 FAME study of low-dose Iluvien (fluocinolone acetonide; Alimera Sciences) show statistically significant improvements in vision in patients with diabetic macular edema, according to a company news release.
…
Gabapentin Failed to Reduce Pain After PRK
Gabapentin (Neurontin; Pfizer, Inc.) did not improve pain after PRK when added to a standard postoperative regimen of topical agents and an oral narcotic, according to a study in the Journal of Cataract and Refractive Surgery.sup1/sup
The single-cente…
Ranibizumab Meets Primary Endpoint in Phase 3 Trial for DME
Patients with diabetic macular edema (DME) who received monthly injections of ranibizumab (Lucentis; Genentech, Inc.) were significantly more likely to gain at least 15 letters of BCVA than those who received sham injections, according to the 24-month …
Blood Glucose Levels Predicted 10-Year Risk of Retinopathy
Hemoglobin A1c and fasting plasma glucose levels can predict the risk of retinopathy 10 years after a baseline examination, according to a study in the Archives of Ophthalmology.sup1/sup
Pascale Massin, MD, PhD, of Hôpital Lariboisière, Paris, and…
Factors Affecting Corneal Graft Survival in Young Patients
Most youths who received corneal transplants had improved visual outcomes, with the highest transplant success occurring in adolescent patients treated for keratoconus, according to a study in Ophthalmology.sup1/sup
In a large, prospective study, rese…
Cell Phone Use Affects Brain Activity
Cell phone exposure was associated with increased brain glucose metabolism in the region closest to the antenna, according to a study in the Journal of the American Medical Association.sup1/sup
In the randomized study, Nora D. Volkow, MD, director of …
Prostate Cancer Therapy Linked to Cataract Development
Patients receiving androgen deprivation therapy (ADT) to
treat prostate cancer may be at a higher risk of developing
cataracts, according to a study in the Annals of Epidemiology.1
Side effects associated with ADT (such as weight gain,
dyslipidemia, an…
IN MEMORY OF JACK A. SINGER, MD
A friend and colleague, Jack A. Singer, MD,
of Randolph, Vermont, died suddenly and
unexpectedly on January 6, 2011.
The son of Harold and Evelyn Singer, Jack
was born in Brooklyn, New York, on
November 23, 1955. He leaves behind his
wife, Sandy, from …
Prevalence of AMD in Americans Declining
The prevalence of age-related macular degeneration
(AMD) in American adults is significantly lower today than
it was 15 years ago, according to the results of a nationally
representative, population-based, cross-sectional study published
in the Archive…
New Indication for Ranibizumab Granted in EU
The European Commission has granted Novartis a new,
broader indication for ranibizumab (Lucentis; Genentech)
to treat patients with visual impairment due to diabetic
macular edema, according to a company news release.
The approval of Lucentis was based…
Inflammation,Improved Visual Acuity in Uveitis With Ozurdex
The Ozurdex dexamethasone intravitreal implant
(Allergan, Inc.) significantly improved intraocular inflammation
and visual acuity in patients with noninfectious intermediate
or posterior uveitis, according to a study in the
Archives of Ophthalmology.1
…
RENÉ LE BERRE, RIVER BLINDNESS PIONEER, DEAD AT 78
René Le Berre, PhD, an entomologist and
pioneer in the diagnosis and treatment of
river blindness, died on December 6, 2010,
in L’Aiguillon-sur-Mer, France, at the age of
78. Dr. Le Berre was responsible for preserving
the sight of millions of peopl…